Medication info
Neobanfurus Tablet

Neobanfurus Tablet

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Shinil Pharmaceutical Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200806640 · Notified 2008.06.17 · Insurance code 653803090

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken regardless of meals with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is applicable when prescribed as valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The maximum antihypertensive effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Ingredients

Manufacturer
Shinil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy. It helps lower blood pressure effectively and reduce the risk of cardiovascular complications. It assists in improving blood pressure control tailored to the patient's condition.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken regardless of meals with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is applicable when prescribed as valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The maximum antihypertensive effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, and should be discontinued immediately upon confirmation of pregnancy. Individuals allergic to the ingredients in this medication or sulfonamide drugs, or those with severe liver or kidney diseases should not take this medication. Patients with electrolyte imbalance, impaired kidney function, elderly individuals, and heart failure patients should take this medication cautiously, frequently checking their blood pressure or kidney function. The hydrochlorothiazide component can cause sensitivity to sunlight, so exposure should be minimized, and if any skin changes occur, a doctor should be consulted immediately. This medication may cause dizziness or drowsiness; caution is needed when driving or operating machinery. Potassium supplements or potassium-containing medications should not be taken without consulting a doctor, and blood potassium levels should be regularly checked. As this medication may interact with other drugs, it is essential to inform the doctor or pharmacist of any current medications. In case of overdose, symptoms such as hypotension, arrhythmias, and electrolyte imbalances may occur, so adherence to the prescribed dosage is crucial, and immediate medical attention is required if unusual symptoms appear. When storing this medication, keep it out of reach of children and store it in its original container to avoid moisture.

Side effects

Headache, dizziness, nasopharyngitis, fatigue, low back pain, cough, upper respiratory infection, diarrhea, joint pain, abdominal pain, epigastric pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, indigestion, shortness of breath, erectile dysfunction, gastroenteritis, sweating, sensory loss, insomnia, hypokalemia, hypotension, influenza, muscle cramps, muscle strain, nausea, nasal congestion, nasal bleeding, throat pain, otitis media, limb pain, paresthesia, oropharyngeal pain, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament sprain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, angioedema, itching, serum sickness, vasculitis, hair loss, renal impairment, myalgia, anaphylactic-like symptoms, hepatitis, kidney failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, exacerbation of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, AST elevation, palpitations, edema, weakness, hypertriglyceridemia, creatine kinase elevation, hemoglobin decrease, serum potassium increase, vasculitis, liver function elevation, angioedema, rash, bullous dermatitis, dizziness, abdominal pain, thrombocytopenia, leukopenia, bone marrow failure, hemolytic anemia, acute respiratory distress syndrome, hypersensitivity reaction, pneumonia, pulmonary edema, hypokalemia, hyperlipidemia, hyponatremia, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic metabolic alkalosis, hyperglycemia, diabetes, diabetic metabolic deterioration, urticaria, skin rash, photosensitivity reaction, necrotizing vasculitis, erythematous lupus-like reaction, recurrence of erythematous lupus, decreased appetite, nausea, vomiting, abdominal discomfort, constipation, gastrointestinal discomfort, pancreatitis, intrahepatic bile duct obstruction, jaundice, orthostatic hypotension, cardiac arrhythmia, sensory loss, sedation, sleep disorder, depression, paresthesia, visual impairment, acute angle-closure glaucoma, choroidal effusion, erectile dysfunction, acute kidney failure, renal impairment, aplastic anemia, erythema multiforme, fever, muscle cramps, weakness, acute angle-closure glaucoma, choroidal effusion, nausea, drowsiness, hypovolemia, arrhythmia, muscle rigidity

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly closed container to protect it from air and moisture. It is advisable to maintain a storage temperature below 30 degrees Celsius.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.